RESUMEN
BACKGROUND AND AIMS: Despite the significant morbidity associated with gastric variceal bleeding, there is a paucity of high-quality data regarding optimal management. EUS-guided coil injection therapy (EUS-COIL) has recently emerged as a promising endoscopic modality for the treatment of gastric varices (GV), particularly compared with traditional direct endoscopic glue injection. Although there are data on the feasibility and safety of EUS-COIL in the management of GV, these have been limited to select centers with particular expertise. The aim of this study was to report the first U.S. multicenter experience of EUS-COIL for the management of GV. METHODS: This retrospective analysis included patients with bleeding GV or GV at risk of bleeding who underwent EUS-COIL at 10 U.S. tertiary care centers between 2018 and 2022. Baseline patient and procedure-related information was obtained. EUS-COIL entailed the injection of .018 inch or .035 inch hemostatic coils using a 22-gauge or 19-gauge FNA needle. Primary outcomes were technical success (defined as successful deployment of coil into varix under EUS guidance with diminution of Doppler flow), clinical success (defined as cessation of bleeding if present and/or absence of bleeding at 30 days' postintervention), and intraprocedural and postprocedural adverse events. RESULTS: A total of 106 patients were included (mean age 60.4 ± 12.8 years; 41.5% female). The most common etiology of GV was cirrhosis (71.7%), with alcohol being the most common cause (43.4%). Overall, 71.7% presented with acute GV bleeding requiring intensive care unit stay and/or blood transfusion. The most common GV encountered were isolated GV type 1 (60.4%). A mean of 3.8 ± 3 coils were injected with a total mean length of 44.7 ± 46.1 cm. Adjunctive glue or absorbable gelatin sponge was injected in 82% of patients. Technical success and clinical success were 100% and 88.7%, respectively. Intraprocedural adverse events (pulmonary embolism and GV bleeding from FNA needle access) occurred in 2 patients (1.8%), and postprocedural adverse events occurred in 5 (4.7%), of which 3 were mild. Recurrent bleeding was observed in 15 patients (14.1%) at a mean of 32 days. Eighty percent of patients with recurrent bleeding were successfully re-treated with repeat EUS-COIL. No significant differences were observed in outcomes between high-volume (>15 cases) and low-volume (<7 cases) centers. CONCLUSIONS: This U.S. multicenter experience on EUS-COIL for GV confirms high technical and clinical success with low adverse events. No significant differences were seen between high- and low-volume centers. Repeat EUS-COIL seems to be an effective rescue option for patients with recurrent bleeding GV. Further prospective studies should compare this modality versus other interventions commonly used for GV.
Asunto(s)
Várices Esofágicas y Gástricas , Hemostasis Endoscópica , Humanos , Femenino , Persona de Mediana Edad , Anciano , Masculino , Hemorragia Gastrointestinal/terapia , Hemorragia Gastrointestinal/tratamiento farmacológico , Várices Esofágicas y Gástricas/terapia , Várices Esofágicas y Gástricas/complicaciones , Hemostasis Endoscópica/efectos adversos , Cianoacrilatos , Estudios Retrospectivos , Estudios Prospectivos , Resultado del Tratamiento , Endosonografía/efectos adversosRESUMEN
INTRODUCTION: Endoscopic ultrasound (EUS)-guided drainage of symptomatic pancreatic fluid collections (PFCs) using the Hot-Axios device has recently been associated with a significant risk of bleeding. This adverse event (AE) seems to occur less frequently with the use of a different device, the Spaxus stent. The aim of the current study was to compare the rates of bleeding between the two stents. METHODS: Patients admitted for treatment of PFCs by EUS plus lumen-apposing metal stent in 18 endoscopy referral centers between 10 July 2019 and 28 February 2022 were identified and their outcomes compared using a propensity-matching analysis. RESULTS: 363 patients were evaluated. After a 1-to-1 propensity score match, 264 patients were selected (132 per group). The technical and clinical success rates were comparable between the two groups. Significantly more bleeding requiring transfusion and/or intervention occurred in the Hot-Axios group than in the Spaxus group (6.8% vs. 1.5%; Pâ=â0.03); stent type was a significant predictor of bleeding in both univariate and multivariate regression analyses (Pâ=â0.03 and 0.04, respectively). Bleeding necessitating arterial embolization did not however differ significantly between the two groups (3.0% vs. 0%; Pâ=â0.12). In addition, the Hot-Axios was associated with a significantly higher rate of overall AEs compared with the Spaxus stent (9.8% vs. 3.0%; Pâ=â0.04). CONCLUSION: Our study showed that, in patients with PFCs, bleeding requiring transfusion and/or intervention occurred significantly more frequently with use of the Hot-Axios stent than with the Spaxus stent, although this was not the case for bleeding requiring embolization.
Asunto(s)
Páncreas , Enfermedades Pancreáticas , Humanos , Estudios Retrospectivos , Stents/efectos adversos , Endosonografía/efectos adversos , Drenaje/efectos adversos , Hemorragia/etiología , Endoscopía Gastrointestinal , Resultado del TratamientoRESUMEN
Parenchymal liver diseases are commonly evaluated by laboratory and imaging studies. However, in some cases a liver biopsy is required. Endoscopic ultrasonography-guided liver biopsy (EUS-LB) has been reported as a procedure with high diagnostic yield (90-100%) with low adverse event profile, but there are not studies which report about the experience and technique in our country. OBJECTIVE: Determinate the effectiveness and the safety of endosonography-guided liver biopsy in liver parenchymal disease. MATERIALS AND METHODS: A prospective study was conducted at a III-2 level of care Public Hospital in Lima, Peru. It included patients over 18 years of age with suspicion of parenchymal liver disease who underwent EUS-LB for study hepatic parenchymal disease since March of 2018 to October of 2022. RESULTS: The diagnostic yield of the biopsies was 77.02%, with a mean length of the sample of 13.98mm (standard deviation 7.34) and a median of 8 complete portal spaces (0-50). Only 31.25% of the procedures were performed with a fine needle biopsy (FNB), finding a significant difference between the type of needle and the diagnostic yield (p=0.01). The most common histopathological diagnosis was autoinmune hepatitis. There were 2.08% of post-procedure complications. CONCLUSIONS: EUS-LB for the diagnosis of liver parenchymal disease had a diagnostic yield close to 80% in our region with a low profile of adverse events. However, more prospectives studies with a larger number of patients are required.
Asunto(s)
Endosonografía , Hepatopatías , Humanos , Adolescente , Adulto , Endosonografía/efectos adversos , Endosonografía/métodos , Estudios Prospectivos , Hepatopatías/diagnóstico , Biopsia con Aguja Fina/métodosAsunto(s)
Hemorragia Gastrointestinal , Hematoma , Humanos , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico/efectos adversos , Endosonografía/efectos adversos , Hemorragia Gastrointestinal/complicaciones , Hematoma/diagnóstico por imagen , Hematoma/etiología , Ultrasonografía Intervencional/efectos adversos , Masculino , Anciano de 80 o más AñosRESUMEN
In the last decades, Endoscopic ultrasound (EUS) has rapidly grown and evolved from being mainly a diagnostic procedure, to being an interventional and therapeutic tool in several pathological clinical scenarios. With the progressive growth in technical expertise and dedicated devices, interventional endoscopic ultrasound procedures (IEUSP) have shown high rates of technical and clinical success, together with a relatively safe profile. However, the description and the standardization of different and specific types of adverse events (AEs) are still scarce in literature, and, consequently, even less the management of AEs. The aim of this study is to critical review and to describe AEs related to each of the main IEUSP, and to provide an overview on the possible management strategies of endoscopic complications. Future studies and guidelines are surely required to reach a better standardization of different AEs and their best management.
Asunto(s)
Endosonografía , Ultrasonografía Intervencional , Humanos , Endosonografía/efectos adversos , Endosonografía/instrumentación , Endosonografía/normas , Endosonografía/métodos , Ultrasonografía Intervencional/efectos adversosRESUMEN
OBJECTIVE: This study aimed to systematically evaluate the efficacy and safety of Endoscopic Ultrasonography (EUS) for the treatment of pancreatic cancer. METHODS: The PubMed, Embase, Web of Science, and Google Scholar databases were searched from the inception of the databases to June 2022. RevMan 5.3.0 software was utilized for data analysis. In total, 13 self-descriptive studies, which enrolled 382 patients, were finally included. RESULTS: It was revealed that EUS for the treatment of pancreatic cancer exhibited a lower incidence of adverse reactions (Relative Risk Ration [RR = 0.23], 95 % Confidence interval [95 % CI 0.23-0.23]), a higher success rate (RR = 0.90, 95 % CI 0.90-0.90), and a low failure rate (RR = 0.06, 95 % CI 0.06-0.06). Moreover, EUS-guided Celiac Plexus Neurolysis (EUS-CPN) not only significantly relieved pancreatic cancer patients' pain (RR = 0.83, 95 % CI 0.83-0.83), but also significantly eliminated pain in some patients (RR = 0.09, 95 % CI 0.09-0.09). The effects of EUS on pancreatic cancer treatment were satisfactory, and few adverse reactions were found. CONCLUSION: Owing to the restricted sample size in this meta-analysis, primarily consisting of descriptive studies, it was imperative to conduct more rigorously designed, multi-center, long-term follow-up, larger sample, and Randomized Controlled Trials (RCTs) to validate the findings.
Asunto(s)
Bloqueo Nervioso , Neoplasias Pancreáticas , Humanos , Endosonografía/efectos adversos , Neoplasias Pancreáticas/diagnóstico por imagen , Neoplasias Pancreáticas/terapia , Dolor Abdominal/etiologíaRESUMEN
BACKGROUND: Radial probe endobronchial ultrasound (radial EBUS) is widely used to diagnose pulmonary lesions; however, the diagnostic value of radial EBUS-guided transbronchial biopsy (TBB) varies, and its complications (especially the risk of bleeding) are not properly understood. OBJECTIVES: In this study, we evaluated the diagnostic performance and rate of complication of this procedure, and investigated the risk factors associated with the procedure-related bleeding events. DESIGN: A retrospective cohort study. METHODS: This was a retrospective study that included consecutive patients who underwent radial EBUS-guided TBB. Radial EBUS was performed under moderate sedation in inpatients or outpatients. The severity of bleeding was graded using the standardized definitions of bleeding. RESULTS: Of 133 patients (median age, 69 years; men 57.1%) included, 41 were outpatients (30.8%). The diagnostic accuracy, sensitivity, and specificity for malignancy were 76.1% (89/117), 71.1% (69/97), and 100% (20/20), respectively. The diagnostic accuracy ranged from 66.9% to 79.0%, depending on the classification of undiagnosed cases as either false negatives or true negatives. Twenty-seven patients (20.3%) developed complications (pneumothorax, 3; pneumonia, 5; complicated pleural effusion, 2; bleeding event grade 2 or higher, 21). Of the 41 outpatients, two developed complications (pneumothorax without intervention, 1; grade 2 bleeding event, 1). Of the 21 patients (15.8%) with procedure-related bleeding events, 18 had grade 2, and three had grade 3 bleeding complications. In multivariate analysis, a large size of ⩾30 mm (adjusted odds ratio (OR), 5.09; p = 0.03) and central lesion (adjusted OR, 3.67; p = 0.03) were significantly associated with the risk of grade 2 or higher bleeding events. CONCLUSION: Our results suggest that radial EBUS-guided TBB is an accurate and safe method for diagnosing pulmonary lesions. Clinically significant procedure-related bleeding was rare. The central location and larger size (⩾30 mm) of pulmonary lesions were risk factors for grade 2 or higher bleeding events.
Asunto(s)
Broncoscopía , Hemorragia , Humanos , Masculino , Femenino , Estudios Retrospectivos , Anciano , Factores de Riesgo , Persona de Mediana Edad , Hemorragia/etiología , Broncoscopía/efectos adversos , Biopsia Guiada por Imagen/efectos adversos , Biopsia Guiada por Imagen/métodos , Endosonografía/efectos adversos , Endosonografía/métodos , Ultrasonografía Intervencional/efectos adversos , Anciano de 80 o más Años , Neoplasias Pulmonares/patología , Valor Predictivo de las Pruebas , Medición de RiesgoRESUMEN
Gastric outlet obstruction (GOO) poses a common and challenging clinical scenario, characterized by mechanical blockage in the pylorus, distal stomach, or duodenum, resulting in symptoms such as nausea, vomiting, abdominal pain, and early satiety. Its diverse etiology encompasses both benign and malignant disorders. The spectrum of current treatment modalities extends from conservative approaches to more invasive interventions, incorporating procedures like surgical gastroenterostomy (SGE), self-expandable metallic stents (SEMSs) placement, and the advanced technique of endoscopic ultrasound-guided gastroenterostomy (EUS-GE). While surgery is favored for longer life expectancy, stents are preferred in malignant gastric outlet stenosis. The novel EUS-GE technique, employing a lumen-apposing self-expandable metal stent (LAMS), combines the immediate efficacy of stents with the enduring benefits of gastroenterostomy. Despite its promising outcomes, EUS-GE is a technically demanding procedure requiring specialized expertise and facilities.
Asunto(s)
Obstrucción de la Salida Gástrica , Gastroenterostomía , Humanos , Gastroenterostomía/efectos adversos , Gastroenterostomía/métodos , Endosonografía/efectos adversos , Endosonografía/métodos , Obstrucción de la Salida Gástrica/diagnóstico por imagen , Obstrucción de la Salida Gástrica/etiología , Obstrucción de la Salida Gástrica/cirugía , Píloro/cirugía , Stents/efectos adversos , Constricción Patológica/complicaciones , Constricción Patológica/cirugíaRESUMEN
INTRODUCTION: Transbronchial needle aspiration guided by endobronchial ultrasonography (EBUSTBNA) has the disadvantage of sometimes offering samples of an unsuitable size for an accurate histo-molecular diagnosis. Transbronchial mediastinal cryobiopsy (CRYOEBUS) is a very novel and additional technique to EBUS-TBNA that allows us to obtain larger and quality samples, improving diagnostic performance. MATERIAL AND METHODS: Descriptive study of 110 patients with lesions and/or mediastinal lymphadenopathy who underwent EBUS-TBNA and CRYO-EBUS in a single procedure. Our objective was to analyze the diagnostic profitability and safety of the technique. RESULTS: CRYO-EBUS obtained samples of 0.42cm on average compared to 0.14cm obtained by EBUS-TBNA. The overall diagnostic performance of the techniques was 60% for EBUS-TBNA and 94.5% for CRYO-EBUS. Furthermore, the latter was more sensitive for the diagnosis of both malignant and benign diseases. With a very high security profile. CONCLUSIONS: The CRYO-EBUS technique is cost-effective and safe, and is superior to EBUS-TBNA. Future studies may confirm our findings.
Asunto(s)
Broncoscopía , Análisis Costo-Beneficio , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico , Mediastino , Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Broncoscopía/métodos , Broncoscopía/economía , Broncoscopía/efectos adversos , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico/efectos adversos , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico/economía , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico/métodos , Adulto , Mediastino/patología , Anciano de 80 o más Años , Endosonografía/métodos , Endosonografía/economía , Endosonografía/efectos adversos , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/diagnóstico por imagen , Neoplasias Pulmonares/diagnóstico , Criocirugía/métodos , Sensibilidad y EspecificidadRESUMEN
Predictive models (PMs) in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) have the potential to improve patient outcomes, enhance diagnostic accuracy, and guide therapeutic interventions. This review aims to summarize the current state of predictive models in ERCP and EUS and their clinical implications. To be considered useful in clinical practice a PM should be accurate, easy to perform, and may consider objective variables. PMs in ERCP estimate correct indication, probability of success, and the risk of developing adverse events. These models incorporate patient-related factors and technical aspects of the procedure. In the field of EUS, these models utilize clinical and imaging data to predict the likelihood of malignancy, presence of specific lesions, or risk of complications related to therapeutic interventions. Further research, validation, and refinement are necessary to maximize the utility and impact of these models in routine clinical practice.
Asunto(s)
Colangiopancreatografia Retrógrada Endoscópica , Endosonografía , Humanos , Colangiopancreatografia Retrógrada Endoscópica/efectos adversos , Colangiopancreatografia Retrógrada Endoscópica/métodos , Endosonografía/efectos adversos , Endosonografía/métodosRESUMEN
Objective: To analyze the risk factors for complications of endoscopic full-thickness resection (EFTR) of upper gastrointestinal submucosal tumors (SMTs). Methods: This was a retrospective observational study. The indications for EFTR included: (1) SMTs originating from the muscularis propria layer and growing out of the cavity or infiltrating the deep part of the muscularis propria layer; (2) SMTs diameter <5 cm; and (3) tumor identified as closely adherent to the serous layer during endoscopic submucosal dissection or endoscopic mucosal resection. This study included patients with SMTs originating from the muscularis propria layer in upper digestive tract, diagnosed preoperatively by endoscopic ultrasonography or computed tomography, who were successfully treated with EFTR. Those with incomplete clinical data were excluded. The clinical data of 154 patients with upper gastrointestinal SMTs who underwent EFTR at the Department of Gastroenterology, First Affiliated Hospital of Soochow University from January 2016 to January 2022 were retrospectively analyzed. Post-EFTR complications (such as delayed perforation, delayed bleeding, and postoperative infection, including electrocoagulation syndrome) were monitored and the risk factors for them were analyzed. Results: Among the 154 study patients, 33 (21.4%) developed complications, including delayed bleeding in three (1.9%), delayed perforation in two (1.3%), and postoperative infection in 28 (18.2%). One patient with bleeding was classified as having a major complication (hospitalized for more than 10 days because of complication). According to univariate analysis, complication was associated with tumor diameter >15 mm, operation time >90 minutes, defect closure method(purse string suture), and diameter of resected specimen ≥20 mm (all P<0.05). Multivariate logistic regression analysis showed that operation time >90 minutes (OR=6.252, 95%CI: 2.530-15.446, P<0.001) and tumor diameter >15 mm (OR=4.843, 95%CI: 1.985-11.817, P=0.001) were independent risk factors for complications after EFTR in patients with upper gastrointestinal SMTs. The independent risk factors for postoperative infection in these patients were operation time>90 minutes (OR=4.993, 95%CI:1.964-12.694, P=0.001) and purse string suture (OR=7.142, 95%CI: 1.953-26.123, P=0.003). Conclusion: Patients with upper gastrointestinal SMTs undergoing EFTR with tumor diameter >15 mm or operation time >90 minutes have a significantly increased risk of postoperative complications. Postoperative monitoring is important for these patients with SMTs.
Asunto(s)
Humanos , Neoplasias Gástricas/cirugía , Resección Endoscópica de la Mucosa/métodos , Gastroscopía/métodos , Estudios Retrospectivos , Endosonografía/efectos adversos , Complicaciones Posoperatorias/etiología , Resultado del Tratamiento , Mucosa Gástrica/cirugíaRESUMEN
RESUMEN Introducción: El drenaje guiado por ecoendoscopía es considerado como la mejor opción para el drenaje de las colecciones liquidas peripancreáticas. No hay reportes en nuestro medio de la experiencia en esta terapia endoscópica. Objetivos: detallar las características, eficacia y seguridad de los drenajes ecoendoscópicos de las colecciones liquidas peripancreáticas en el Hospital Nacional Edgardo Rebagliati Martins. Material y métodos: se realizó un estudio transversal retrospectivo de todos los pacientes con colecciones liquidas peripancreáticas sintomáticas sometidos a drenaje ecoguiado. Se analizaron variables demográficas, características ecoendoscópicas asociadas al procedimiento terapéutico y dispositivos empleados. La eficacia se evaluó con la tasa de éxito técnico y de éxito clínico. La seguridad se evaluó en base a las principales complicaciones inmediatas y posteriores. Se empleó estadística descriptiva básica. Resultados: Se realizaron 17 drenajes ecoguiadas de colecciones peripancreáticas (10 pseudoquistes y 7 necrosis pancreáticas encapsuladas o WON) en 17 pacientes: 9 mujeres (52,9%) y 8 hombres (47,1%). El rango de edad de los pacientes fue de 26-72 años, con una mediana de 59 años. El tamaño promedio de las colecciones liquidas fue 14,8 cm con un rango de 8-24 cm. El acceso transgástrico se empleó en 16 casos (94,1%) y el acceso transduodenal en 1 caso (5,9%). Se empleó prótesis plástica (6 casos), prótesis metálica autoexpandibles (SEMS) biliar (4 casos) y prótesis de aposición luminal (LAMS) en 7 casos. El éxito técnico fue del 100% (17 pacientes), mientras que el éxito clínico fue de 70,6% (12 pacientes). Las complicaciones ocurrieron en 41,2%: infección de colección (2 casos), perforación, sangrado en zona de drenaje, obstrucción de prótesis plástica, migración de prótesis al interior de colección y al lumen gástrico (1 caso cada uno). El manejo quirúrgico de éstas complicaciones fue necesaria en 3 casos, mientras que en los otros 4 casos solo requirió manejo médico - endoscópico. Conclusiones: los drenajes guiados por ecoendoscopía de las colecciones liquidas peripancreáticas tienen alta tasa de éxito técnico y clínico con reducido porcentaje de complicaciones.
ABSTRACT Introduction: Endoscopic ultrasound (EUS) guided drainage is considered the best option for peripancreatic fluid collections drainage. There are no previous reports in our country of this type of endoscopic therapy. Objectives: To detail the characteristics, efficacy and safety of EUS-guided drainage of peripancreatic fluid collections at Edgardo Rebagliati Martins National Hospital. Materials and methods: We carried out a retrospective cross-sectional study of all patients who underwent EUS-guided drainage of symptomatic peripancreatic fluid collections. Demographics, procedure-related endosonographic features and devices used were analyzed. We assessed the effectiveness with technical and clinical success rate. Clinical safety was assessed based on major immediate and delayed adverse events. Basic descriptive statistics was used. Results: A total of 17 patients (9 women, 52.9% and 8 men, 47.1%) with peripancreatic fluid collections (10 pseudocysts and 7 walled-off necrosis) underwent EUS-guided drainage. The median age of the patients was 59 years (range 26 - 72 years). The mean diameter of the fluid collections was 14.8 cm (range 8-24 cm). Transgastric route was used in 16 cases (94.1%) and transduodenal route in 1 case (5.9%). Plastic stent (6 cases), biliary self expanding metal stent (4 cases) and lumen apposing stent (7 cases) were used. The technical success rate was 100% (17 patients), while clinical success rate was 70.6% (12 patients). Adverse events occurred in 41.2%: infection (2 cases), perforation, bleeding, plastic stent occlusion, stent migration into the collection cavity and out of the collection cavity (1 case each one). Surgical management of adverse events was necessary in 3 cases, while the 4 other cases only required medical - endoscopic management. Conclusions: EUS-guided drainage of peripancreatic fluid collections have a high technical and clinical success rate with a low percentage of adverse events.
Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Pancreáticas/terapia , Drenaje/métodos , Ultrasonografía Intervencional/métodos , Endosonografía/métodos , Enfermedades Pancreáticas/diagnóstico por imagen , Drenaje/efectos adversos , Estudios Transversales , Estudios Retrospectivos , Resultado del Tratamiento , Ultrasonografía Intervencional/efectos adversos , Endosonografía/efectos adversosRESUMEN
Las reacciones anafilácticas intraoperatorias son impredecibles, infrecuentes y pueden poner en riesgo al paciente. Tienen una incidencia de 1/10 000 a 1/20 000 produciéndose en la mayoría de los casos por bloqueantes musculares, látex y antibióticos. No hay estadística de las reacciones alérgicas sistémicas durante otros procedimientos médicos. El estudio diagnóstico posterior a una reacción es complejo debiendo incluir toda la medicación utilizada en el procedimiento. En este estudio retrospectivo describimos 15 pacientes, de los cuales 10 tuvieron reacciones anafilácticas en un procedimiento quirúrgico, 2 en endoscopías y 1 en una ecografía transvaginal. Los dos pacientes restantes presentaron una reacción alérgica sistémica durante una ecografía transvaginal y un procedimiento odontológico. Estudiamos los pacientes con toda la medicación utilizada, incluimos látex y, eventualmente, los detergentes y desinfectantes, de haber sido empleados. Tres de las 10 cirugías no pudieron realizarse por desarrollarse la reacción durante la inducción anestésica, en cinco casos debieron interrumpirse y solo en dos se terminaron. Las reacciones posteriores a endoscopías fueron severas, requiriendo internación en terapia intensiva; las reacciones en ecografías transvaginales y procedimientos odontológicos fueron asistidas en emergencias. Los agentes causales en las cirugías incluyeron bloqueantes musculares, látex, cefalosporina, azul patente y ranitidina; en endoscopías el agente causal fue el orto-ftalaldehído (OPA), en las ecografías transvaginales el látex y en el procedimiento odontológico la amoxicilina. El objetivo de este artículo es describir la etiología de las reacciones alérgicas sistémicas y anafilácticas intraoperatorias y en procedimientos médicos, recalcando su gravedad y la necesidad de su identificación.
Anaphylaxis during anesthesia is an unpredictable, severe, and rare reaction. It has an incidence of 1/10 000 to 1/20 000 surgeries. In most series, the responsible drugs include neuromuscular blocking agents, latex, or antibiotics. The frequency and etiology of systemic allergic reactions in other medical procedures are largely unknown. The identification of responsible drugs of anaphylaxis is a complex task, requiring testing of all medications and substances used during surgery. We describe our experience in a retrospective study of 15 patients. Ten subjects developed anaphylaxis during surgery, two in endoscopic studies and one in a trans-vaginal ultrasound. The remaining two subjects, one in a trans-vaginal ultrasound and another during a dental procedure had a systemic allergic reaction. We studied all patients with all medications administered during the procedures, including latex and detergents and disinfectants. Three surgeries had to be suspended at induction of anesthesia, five were stopped incomplete and two were completed. Both patients that presented a reaction during endoscopy required intensive care unit admission and the rest were observed in a Hospital. The responsible drugs during surgery anaphylaxis were neuromuscular blocking agents, latex, patent blue, and ranitidine. Ortho-phthalaldehyde (OPA) was identified during endoscopic studies; latex was responsible in transvaginal ultrasounds; and amoxicillin in the dental procedure. The aim of the present article is to review our experience studying allergic systemic reactions and anaphylaxis during general anesthesia and medical procedures, emphasizing the severity of these reactions and the need for causative drug identification.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Ecocardiografía Transesofágica/efectos adversos , Endosonografía/efectos adversos , Endoscopía/efectos adversos , Hipersensibilidad/etiología , Anafilaxia/etiología , Complicaciones Intraoperatorias/etiología , Procedimientos Quirúrgicos Operativos/efectos adversos , Estudios RetrospectivosRESUMEN
No abstract available.
Asunto(s)
Adulto , Femenino , Humanos , Coledocostomía/efectos adversos , Duodeno/lesiones , Endosonografía/efectos adversos , Ictericia Obstructiva/diagnóstico por imagen , Stents Metálicos Autoexpandibles/efectos adversosRESUMEN
BACKGROUND/AIMS: Endoscopic therapy with endoscopic retrograde cholangiopancreatography (ERCP) has been suggested as an effective diagnostic and therapeutic tool for biliary and pancreatic disorders during pregnancy. In this report, we describe our experiences with pancreatobiliary endoscopic procedures during pregnancy. METHODS: We reviewed ERCP and endoscopic ultrasonography (EUS) procedures that were performed at a single tertiary care referral center between January 2002 and October 2013. Medical records were reviewed for the procedure indication, the duration of fluoroscopy, postprocedure complications, etc. Pregnancy outcomes and fetal complications were identified by chart review and phone calls to patients. RESULTS: A total of 10 ER-CPs and five EUSs were performed in 13 pregnant patients: four of whom underwent the procedure in the first trimester, eight in the second trimester, and one in the third trimester. Indications for endoscopic therapy included gallstone pancreatitis, obstructive jaundice with common bile duct (CBD) stone, asymptomatic CBD stone, pancreatic cyst, choledochal cyst, and acute cholecystitis. Only one patient had a complication, which was postprocedural hyperamylasemia. Two patients underwent an artificial abortion, one according to her own decision and the other due to an adverse drug reaction. CONCLUSIONS: ERCP seems to be effective and safe for pregnant women. Additionally, EUS can be an alternative to ERCP during pregnancy.
Asunto(s)
Adulto , Femenino , Humanos , Embarazo , Adulto Joven , Enfermedades de las Vías Biliares/cirugía , Colangiopancreatografia Retrógrada Endoscópica/efectos adversos , Endosonografía/efectos adversos , Feto , Procedimientos Quirúrgicos Obstétricos/efectos adversos , Enfermedades Pancreáticas/cirugía , Complicaciones del Embarazo/cirugía , Resultado del Embarazo , Estudios RetrospectivosRESUMEN
No abstract available.
Asunto(s)
Femenino , Humanos , Embarazo , Enfermedades de las Vías Biliares/cirugía , Colangiopancreatografia Retrógrada Endoscópica/efectos adversos , Endosonografía/efectos adversos , Procedimientos Quirúrgicos Obstétricos/efectos adversos , Enfermedades Pancreáticas/cirugía , Complicaciones del Embarazo/cirugíaRESUMEN
BACKGROUND: The incidence of bacteremia after endoscopic ultrasonography (EUS) or EUS-guided fine-needle aspiration (EUS-FNA) is between 0% and 4%, but there are no data on this topic in cirrhotic patients. Aim To prospectively assess the incidence of bacteremia in cirrhotic patients undergoing EUS and EUS-FNA.Patients and methodsWe enrolled 41 cirrhotic patients. Of these, 16 (39%) also underwent EUS-FNA. Blood cultures were obtained before and at 5 and 30 min after the procedure. When EUS-FNA was used, an extra blood culture was obtained after the conclusion of radial EUS and before the introduction of the sectorial echoendoscope. All patients were clinically followed up for 7 days for signs of infection.ResultsBlood cultures were positive in 16 patients. In 10 patients, blood cultures grew coagulase-negativeStaphylococcus, Corynebacterium species, Propionibacterium species or Acinetobacterium Lwoffii, which were considered contaminants (contamination rate 9.8%, 95% CI: 5.7-16%). The remaining 6 patients had true positive blood cultures and were considered to have had true bacteremia (15%, 95% CI: 4-26%). Blood cultures were positive after diagnostic EUS in five patients but were positive after EUS-FNA in only one patient. Thus, the frequency of bacteremia after EUS and EUS-FNA was 12% and 6%, respectively (95% CI: 2-22% and 0.2-30%, respectively). Only one of the patients who developed bacteremia after EUS had a self-limiting fever with no other signs of infection. CONCLUSION: Asymptomatic Gram-positive bacteremia developed in cirrhotic patients after EUS and EUS-FNA at a rate higher than in non-cirrhotic patients. However, this finding was not associated with any clinically significant infections
INTRODUCCIÓN: La incidencia de bacteriemia después de una ultrasonografía endoscópica (USE) o USE con punción aspirativa con aguja fina (USE-PAAF) se sitúa entre el 0-4%. No existen datos acerca de la incidencia en pacientes con cirrosis hepática. OBJETIVO: Evaluar prospectivamente la incidencia de bacteriemia en pacientes cirróticos sometidos a USE y USE-PAAF. PACIENTES Y MÉTODOS: Se incluyeron un total de 41 pacientes. Dieciséis (39%) fueron sometidos también a USE-PAAF. Se realizaron hemocultivos antes y a los 5 y 30 minutos después del procedimiento. Cuando se practicó USE-PAAF se obtuvo una muestra de sangre adicional después de acabar la USE radial y antes de la introducción del ecoendoscopio sectorial. Todos los pacientes fueron seguidos durante 7 días. RESULTADOS: Los hemocultivos fueron positivos en 16 pacientes. En 10 pacientes crecieron gérmenes que fueron considerados contaminantes (tasa de contaminación 9,8%, IC 95%: 5,7-16%). Los 6 pacientes restantes tuvieron hemocultivos positivos por gérmenes no contaminantes y fueron considerados verdaderas bacteriemias (15%, IC 95%: 4-26%). En 5 pacientes los hemocultivos fueron positivos después de la USE diagnóstica y solo en uno después de la USE-PAAF. Por lo tanto, la frecuencia de bacteriemia asociada a USE y USE-PAAF fue 12 y 6%, respectivamente (IC 95%: 2-22% y 0,2-30%, respectivamente). Solo uno de los pacientes presentó bacteriemia sintomática tras la USE que consistió en fiebre autolimitada sin otros signos de infección. CONCLUSIÓN: Los pacientes cirróticos presentan una incidencia de bacteremia asintomática por gérmenes gram-positivos después de la USE (con o sin PAAF) mayor que los pacientes sin esta patología. Sin embargo, este hecho no se asocia a una mayor incidencia de infecciones clínicamente significativas
Asunto(s)
Humanos , Bacteriemia/epidemiología , Endosonografía/efectos adversos , Cirrosis Hepática/complicaciones , Profilaxis Antibiótica , Estudios ProspectivosAsunto(s)
Humanos , Masculino , Anciano , Endosonografía/efectos adversos , Endoscopía/efectos adversos , Endoscopía , Hemorragia Gastrointestinal/complicaciones , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/etiología , Angiodisplasia , Gastroscopía/efectos adversos , Colonoscopía/efectos adversos , Intestino Delgado/patología , Intestino DelgadoRESUMEN
BACKGROUND: Surgery is the traditional treatment for symptomatic pancreatic pseudocysts, but the morbidity is still too high. Minimally invasive endoscopic approaches have been encouraged. AIMS: To evaluate the efficacy of endoscopic ultrasound-guided endoscopic transmural drainage of pancreatic pseudocysts. METHODS: From January, 2003 to August, 2006, 31 consecutive symptomatic patients submitted to 37 procedures at the same endoscopic unit were retrospectively analysed. Chronic and acute pancreatitis were found in, respectively, 17 (54.8 percent) and 10 (32.3 percent) cases. Bulging was present in 14 (37.8 percent) cases. Cystogastrostomy or cystoduodenostomy were created with an interventional linear echoendoscope under endosonographic and fluoroscopic control. By protocol, only a single plastic stent, without nasocystic drain, was used. Straight or double pigtail stents were used in, respectively, 22 (59.5 percent) and 15 (40.5 percent) procedures. RESULTS: Endoscopic ultrasound-guided transmural drainage was successful in 29 (93.5 percent) patients. Two cases needed surgery, both due to procedure-related complications. There was no mortality related to the procedure. Twenty-four patients were followed-up longer than 4 weeks. During a mean follow-up of 12.6 months, there were six (25 percent) symptomatic recurrences due to stent clogging or migration, with two secondary infections. Median time for developing complications and recurrence of the collections was 3 weeks. These cases were successfully managed with new stents. Complications were more frequent in patients treated with straight stents and in those with a recent episode of acute pancreatitis. CONCLUSIONS: Endoscopic transmural drainage provides an effective approach to the management of pancreatic pseudocysts.
RACIONAL: A abordagem cirúrgica é o tratamento tradicional para os pseudocistos sintomáticos de pâncreas, contudo a morbidade permanece elevada. Terapêuticas endoscópicas minimamente invasivas têm sido encorajadas. OBJETIVO: Avaliar a eficácia da drenagem endoscópica transmural de pseudocistos de pâncreas guiada por ecoendoscopia. MÉTODOS: De janeiro de 2003 a agosto de 2006, 31 pacientes sintomáticos submetidos a 37 procedimentos no mesmo centro de referência foram analisados retrospectivamente. Pancreatite crônica e aguda foram detectadas em, respectivamente, 17 (54,8 por cento) e 10 (32,3 por cento) pacientes. Abaulamento da parede esteve presente em 14 (37,8 por cento) casos. Cistogastrostomias ou cistoduodenostomias foram criadas com um ecoendoscópio linear sob controle endosonográfico e fluoroscópico. Como rotina, apenas uma única prótese plástica foi empregada, sem dreno nasocístico. Próteses retas ou " double pigtail" foram empregadas em, respectivamente, 22 (59,5 por cento) e 15 (40,5 por cento) procedimentos. RESULTADOS: A drenagem endoscópica foi adequada em 29 (93,5 por cento) pacientes. Dois casos necessitaram intervenção cirúrgica por complicações do procedimento. Não houve mortalidade relacionada ao procedimento. Vinte e quatro pacientes contaram com seguimento superior a 4 semanas. Durante seguimento médio de 12,6 meses, ocorreram seis (25 por cento) recurrências sintomáticas por obstrução ou migração da prótese, com infecção secundária em dois casos, todos manejados com novas próteses. O tempo mediano para ocorrência de complicações foi de 3 semanas. Complicações tardias foram mais freqüentes em pacientes tratados com próteses retas e naqueles com história recente de pancreatite aguda. CONCLUSÔES: A drenagem endoscópica transmural constitui abordagem efetiva para o manejo dos pseudocistos de pâncreas.
Asunto(s)
Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Drenaje/métodos , Endosonografía/métodos , Enfermedades Pancreáticas/cirugía , Seudoquiste Pancreático/cirugía , Ultrasonografía Intervencional/métodos , Enfermedad Aguda , Enfermedad Crónica , Drenaje/efectos adversos , Endosonografía/efectos adversos , Enfermedades Pancreáticas , Seudoquiste Pancreático/ultraestructura , Estudios Retrospectivos , Resultado del Tratamiento , Ultrasonografía Intervencional/efectos adversosRESUMEN
Introducción: las minisondas transendoscópicas (MST) poseenhoy en día unas indicaciones precisas, pero podrían ser en elfuturo una alternativa a la Ultrasonografía Endoscópica (USE) radialy sectorial en el área diagnóstica.Pacientes y método: desde noviembre de 1996 hasta juliodel 2004, hemos realizado 620 exploraciones con MST (124 enlos últimos 12 meses del año 2003; con una media de 11 exploraciones/mes actualmente).Veinte exploraciones se realizaron con una Microvasive Endode 7,5 MHz y 2,6 mm de diámetro con el sistema conocido depre-carga, que utilizamos desde 1999-2004 (280 E). El canal detrabajo utilizado fue de 3,2 mm, mientras que en con el resto delas MST se utilizó un canal de trabajo de 2,8 mm.Resultados: con la misma MST de Microvasive se realizaron20 exploraciones del tracto digestivo rompiéndose al intentar introducirlapor la papila.Actualmente utilizamos Olympus G20-29R de 20 MHz, 2,2mm, con guía, para el estudio intraductal.Con la misma MST de Fuji (12 ó 7,5 MHz) hemos realizado100 exploraciones del tracto digestivo.Órgano a explorar: el esófago y el estómago 60%, el recto y elcolon el 30%, miscelánea (duodeno, papila, vía biliar) 10%.Indicación: estadificación del cáncer 35%, lesión submucosa30%, miscelánea 35% (incluyendo un 20% de patología esofágicano tumoral).Complicaciones: aspiración, perforación y mortalidad del 0%.Morbilidad del 10% a expensas del dolor abdominal provocadopor la realización de la endoscopia.Todas las estenosis se pudieron atravesar, menos una estenosismaligna rectal.Conclusiones: en un periodo de 93 meses (1996-2004) hemosrealizado 620 exploraciones con MST, actualmente con unpromedio de 11 exploraciones/mes. La durabilidad de la MSTestá alrededor de las 100 exploraciones del tracto digestivo. En el60% de los casos se exploró el esófago y el estómago. La indicacionesfundamentales fueron la estadificación del cáncer del tubodigestivo y las lesiones submucosas (65%). Los porcentajes de perforacióny mortalidad fueron del 0%
Introduction: transendoscopic miniprobes (TEMPs) havenowadays precise indications, but may become a diagnostic alternativeto both radial and sectorial endoscopic ultrasonography(EUS) in the near future.Patients and methods: from November 1996 to July 2004we carried out 620 examinations using TEMPs (124 during thelast 12 months in 2003, with currently a mean of 11 examinations/month). Twenty explorations were performed with radial,12.5 MHz (20 mm penetration), 6.2 F (2 mm diameter), 950 mmor 2000 mm Microvasive Endosound probes. Twenty explorationswere performed using a 12 MHz (29 mm mean penetration)or 20 MHz (18 mm penetration) Olympus UM-2R/3R, orwith a 12 MHz UM-DP12-25R or 20 MHz UM-DP20-25 R DPRfittedOlympus probe, 2.5 mm in diameter and 2050 mm inlength. A 20 MHz, 2.2 mm, wire-guided G20-29R was used forintraductal studies.In all, 580 examinations were carried out with both radial andlinear, 12 MHz (240 E) or 20 MHz (60 E) Fuji probes, 2.6 mm indiameter and 1900 mm in length; and with a 7.5 MHz, 2.6 mmradial balloon microprobe with the well-known preload systemthat we have been using during the 1999-2004 period (280 E).Here we used a 3.2 mm working channel, whereas a 2.8 mmworking channel was used with the remaining TEMPs.Results: twenty GI-tract examinations were performed withone Microvasive probe, which broke down when attempting itspassage through the papilla.Currently we use a 20 MHz, 2.2 mm Olympus G20-29R guidedmicroprobe for intraductal studies.We performed 100 gut examinations using one single FujiTEMP (12 or 7.5 MHz).Organs explored included: esophagus and stomach, 60%; rectumand colon, 30%; other (duodenum, papilla, bile ducts), 10%.Indications: cancer staging, 35%; submucosal lesions, 30%;other, 35% (including 20% of esophageal non-tumoral conditions).Complications: aspiration, perforation, and mortality, 0%.Morbidity, 10%, at the expense of abdominal pain as induced byendoscopy itself.All strictures were successfully passed, except for one malignantstenosis in the rectum.Conclusions: during a 93-month period (1996-2004) weperformed 620 explorations with TEMPs, with a current averageof 11 examinations/month. TEMP durability is around 100 gutexplorations. The esophagus and stomach were examined in 60%of cases. Primary indications included gut cancer staging and submucosallesions (65%). Perforation and mortality rates amountedto 0%